ICH Q3D Guideline for Elemental Impurities – How BASF supports its pharmaceutical customers towards compliance

Format: External webinar | Document type: Webinar

How BASF supports its pharmaceutical customers towards compliance
On December 19, 2014, the Guideline "ICH Q3D - Elemental Impurities" was issued by the ICH, providing a global policy for limiting metal impurities qualitatively and quantitatively in drug products and ingredients. The required comprehensive view on a products’ elemental impurities from all sides will cause major challenges for the pharmaceutical and chemical industry. In this webinar Dr. Dorothee Kriha will provide a close look at the core elements of the Guideline, outline challenges and give insight into what BASF as pharmaceutical ingredient supplier has done to help customers to comply with the new requirements for elemental impurities right from the start.


Dr Dorothee Kriha, Regulatory Affairs Manager, BASF SE Dr Dorothee Kriha Regulatory Affairs Manager

Jan Bebber, Platform Marketing Pharma Ingredients, BASF SE Jan Bebber Platform Marketing Pharma Ingredients

Related resources from BASF Pharma Ingredients and Services

Supplier info centre